Showing results (171-180 of 6,279) with videos related to

Sort By:
Pageof 628
Diabetes, Obesity & Metabolism|February 4, 2017
Scriptaid enhances skeletal muscle insulin action and cardiac function in obese miceVidhi Gaur, Timothy Connor, Kylie Venardos, et al.
Diabetes, Obesity & Metabolism|March 4, 2017
Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetesGuillermo E Umpierrez, David O'Neal, Andres DiGenio, et al.
Diabetes, Obesity & Metabolism|March 21, 2017
Decreased insulin-stimulated brown adipose tissue glucose uptake after short-term exercise training in healthy middle-aged menPiryanka Motiani, Kirsi A Virtanen, Kumail K Motiani, et al.
Diabetes, Obesity & Metabolism|March 16, 2017
The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patientsSergei I Petrykiv, Gozewijn D Laverman, Dick de Zeeuw, et al.
Diabetes, Obesity & Metabolism|March 16, 2017
Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?Daniël H van Raalte, C Bruce Verchere
Diabetes, Obesity & Metabolism|March 16, 2017
Association between diabetes mellitus and incidence of intracerebral haemorrhage and case fatality rates: A retrospective population-based cohort studyMarion Boulanger, Rustam Al-Shahi Salman, Jan Kerssens, et al.
Diabetes, Obesity & Metabolism|March 22, 2017
Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participantsManjusha Kulkarni, Randi E Foraker, Ann M McNeill, et al.
Diabetes, Obesity & Metabolism|February 4, 2021
Rates and estimated cost of primary care consultations in people diagnosed with type 2 diabetes and comorbidities: A retrospective analysis of 8.9 million consultationsBriana Coles, Francesco Zaccardi, Sam Seidu, et al.
Diabetes, Obesity & Metabolism|November 18, 2003
Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failureY Altuntas, B Ozen, B Ozturk, et al.
Diabetes, Obesity & Metabolism|November 18, 2003
Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targetsP Hollander, R Ratner, M Fineman, et al.
Pageof 628